ALTUV.PA BIO-UV (EURONEXT) +12.43% intraday 13 Mar 2026: volume surge signals interest

ALTUV.PA stock rallied intraday, trading at €1.52 after a +12.43% move on 13 Mar 2026. The jump came with 20,380 shares traded, above the 14,396 average, marking a clear high-volume mover on EURONEXT. Traders are watching liquidity and momentum after the stock hit a day high of €1.54. We assess drivers, valuation, technicals, and a model forecast ahead of the company’s earnings on 2026-04-01.

Intraday price action for ALTUV.PA stock

ALTUV.PA stock opened at €1.40 and reached a day high of €1.54 before settling at €1.52. The rise outpaced the 50-day average of €1.38 but remains below the 200-day average of €1.63.

Volume and technicals for ALTUV.PA stock

Volume was 20,380 versus an average of 14,396, giving a relative volume of 2.44 and confirming heavy intraday interest. Momentum indicators show RSI 66.43 and ADX 32.30, while CCI 277.71 registers overbought readings, suggesting a strong short-term trend.

Fundamentals and valuation of ALTUV.PA stock

BIO-UV Group (ALTUV.PA) posts EPS €0.06 and a reported PE of 23.20, with TTM PE near 19.71. Key valuation metrics include PB 0.46 and P/S 0.50, and the company has a current ratio of 2.11 and debt-to-equity of 0.51.

Meyka AI grade and stock outlook for ALTUV.PA stock

Meyka AI rates ALTUV.PA with a score out of 100: 70.30 (Grade B+, Suggestion: BUY). This grade factors S&P 500 and sector comparisons, financial growth, key metrics, forecasts, and analyst consensus. The rating highlights strong free cash flow yield 11.88% and low PB, balanced by weaker operating margins.

Meyka AI’s forecast and price targets for ALTUV.PA stock

Meyka AI’s forecast model projects a yearly price of €1.089 versus the current €1.52, implying downside near -28.36%. Scenario targets: conservative €1.00 (‑34.21%), model €1.09 (‑28.36%), optimistic €2.12 (+39.47%). Forecasts are model-based projections and not guarantees.

Risks and opportunities for ALTUV.PA stock

Opportunities include exposure to water treatment and international ballast-water demand, and a year high of €2.12 signals upside possible on contract news. Risks include slim operating margins, a long cash conversion cycle with DSO 85.79 days, and volatile earnings growth last year.

Final Thoughts

Short-term traders will find ALTUV.PA stock attractive today because of the +12.43% intraday move and 2.44 relative volume. Technicals point to a strong trend, with RSI 66.43 and ADX 32.30, but indicators also show overbought pressure. On fundamentals, BIO-UV’s PB 0.46 and free cash flow yield 11.88% support value arguments. However, operating margins and recent net income contraction are constraints. Meyka AI’s forecast model projects €1.089 for the year, implying around -28.36% from the current €1.52, while a bullish case to the year high €2.12 would imply +39.47%. Traders should weigh intraday momentum against earnings on 2026-04-01 and sector performance in Industrials. Meyka AI, our AI-powered market analysis platform, flags this as a high-volume mover with mixed signals; adjust risk sizing and use stop discipline when trading ALTUV.PA stock. Forecasts are model-based projections and not guarantees.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.